Cargando…

Parathyroid Hormone Levels May Predict Nonalcoholic Steatohepatitis in Morbidly Obese Patients

BACKGROUND: Obesity as a worldwide health problem is associated with nonalcoholic steatohepatitis (NASH). Since severe liver injury may be present in asymptomatic obese patients and a definite diagnosis of nonalcoholic steatohepatitis can only be made after an invasive procedure of liver biopsy, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghoghaei, Morteza, Taghdiri, Foad, Khajeh, Elias, Azmoudeh Ardalan, Farid, Sedaghat, Mojtaba, Hosseini Shirvani, Sepideh, Zarei, Shadi, Toolabi, Karamollah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539792/ https://www.ncbi.nlm.nih.gov/pubmed/26300934 http://dx.doi.org/10.5812/hepatmon.29697v2

Ejemplares similares

Minimum Number of Required Sessions for Attaining Basic Skills in Laparoscopic Surgery by General Surgery Residents; an Experimental Report
por: Noaparast, Morteza, et al.
Publicado: (2019)

Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis
por: Styczynski, Grzegorz, et al.
Publicado: (2021)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis
por: Wong, Robert J., et al.
Publicado: (2019)

Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients
por: Doulberis, Michael, et al.
Publicado: (2020)

Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients
por: Wu, Hua-Chien, et al.
Publicado: (2023)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Tuberculous Liver Abscess in an Immunocompetent Patient: a Case Report
por: Shokouhi, Shervin, et al.
Publicado: (2014)

An Unusual Cause of Upper Gastrointestinal Tract Obstruction
por: Toolabi, Karamollah, et al.
Publicado: (2019)

LC/MS-Based Untargeted Metabolomics Study in Women with Nonalcoholic Steatohepatitis Associated with Morbid Obesity
por: Bertran, Laia, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Wilson's disease masquerading as nonalcoholic steatohepatitis
por: Mahmood, Sabina, et al.
Publicado: (2009)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
por: Lam, Mindy C.W., et al.
Publicado: (2012)

The effect of β-caryophyllene on nonalcoholic steatohepatitis
por: Arizuka, Naoya, et al.
Publicado: (2017)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2018)

Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019)

The regulatory state of nonalcoholic steatohepatitis and metabolism
por: Omokaro, Stephanie O., et al.
Publicado: (2020)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
por: Sumida, Yoshio, et al.
Publicado: (2020)

Role of Neutrophils in the Pathogenesis of Nonalcoholic Steatohepatitis
por: Hwang, Seonghwan, et al.
Publicado: (2021)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
por: Xiang, Hui, et al.
Publicado: (2022)

Human Nonalcoholic Steatohepatitis on a Chip
por: Freag, May S., et al.
Publicado: (2020)

How accurate is the visual estimation of bowel length by endoscopic surgeons?
por: Mirzaee, Sahar, et al.
Publicado: (2022)

Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitis
por: Kruger, Annie J., et al.
Publicado: (2018)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis
por: Chen, Hui, et al.
Publicado: (2022)

Minimal access mediastinal surgery: One or two lung ventilation?
por: Toolabi, Karamollah, et al.
Publicado: (2009)

The Comparison of Postoperative Pain, Nausea, and Vomiting between Veress Needle Entry and Direct Trocar Entry Methods in Patients Undergoing Laparoscopic Cholecystectomy
por: Toolabi, Karamollah, et al.
Publicado: (2021)

Ileal intussusception secondary to both lipoma and angiolipoma: a case report
por: Aminian, Ali, et al.
Publicado: (2009)

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis
por: Yalniz, Mehmet, et al.
Publicado: (2006)

Nonalcoholic Steatohepatitis in a Patient with Ataxia-Telangiectasia
por: Caballero, Trinidad, et al.
Publicado: (2014)

Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
por: Gitto, S., et al.
Publicado: (2015)

Nonalcoholic Steatohepatitis: Involvement of the Telomerase and Proinflammatory Mediators
por: Serhal, Rim, et al.
Publicado: (2015)

Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
por: Nagaya, Tadanobu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7818mpm3585ecfemneojm8bru3